{{Rsnum
|rsid=7034462
|Chromosome=9
|position=99095919
|Orientation=plus
|GMAF=0.06703
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 88.5 | 10.6 | 0.9
| HCB | 88.1 | 11.9 | 0.0
| JPT | 93.7 | 6.3 | 0.0
| YRI | 88.3 | 11.7 | 0.0
| ASW | 91.1 | 8.9 | 0.0
| CHB | 88.1 | 11.9 | 0.0
| CHD | 88.1 | 11.9 | 0.0
| GIH | 88.8 | 10.2 | 1.0
| LWK | 80.7 | 18.3 | 0.9
| MEX | 91.4 | 6.9 | 1.7
| MKK | 80.6 | 19.4 | 0.0
| TSI | 82.2 | 17.8 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22292045
|Title=TGFBR1 Intralocus Epistatic Interaction as a Risk Factor for Colorectal Cancer
|OA=1
}}

{{PMID Auto
|PMID=20500843
|Title=Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}